Trial intelligence / Profile preview

Intrathecal Baclofen Bolus for Neuropathic Pain in SCI

NCT02705950Completed

Sponsor
Institut Guttmann
Start
Dec 2014
Primary completion
Aug 2017
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in neuropathic pain comparing Intrathecal Baclofen with Placebo (2 arms). Primary endpoint: Neuropathic Pain Inventory Scale at 4 hours. Started Dec 2014; status: completed.

02

Drugs

baclofen
03

Conditions

neuropathic pain

Beyond the preview

Go deeper on NCT02705950.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02705950.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call